Previous Close | 2.5300 |
Open | 2.5900 |
Bid | 2.5700 x 100 |
Ask | 2.6700 x 100 |
Day's Range | 2.4100 - 2.6200 |
52 Week Range | 0.8600 - 4.6500 |
Volume | |
Avg. Volume | 118,761 |
Market Cap | 173.527M |
Beta (5Y Monthly) | 2.81 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.3900 |
Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.50 |
CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 10:20 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the co
One of the biggest stories of last week was how Generation Bio Co. ( NASDAQ:GBIO ) shares plunged 21% in the week since...
Generation Bio ( NASDAQ:GBIO ) Second Quarter 2024 Results Key Financial Results Revenue: US$4.09m (up 365% from 2Q...